Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 125

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 16
Chunk 125
---
Not applicable.

-91-

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    Dated: February 28, 2025
     
    SAREPTA THERAPEUTICS, INC.

    By:
    /s/ Douglas S. Ingram

    Douglas S. Ingram

    President and Chief Executive Officer